Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Jan-Feb;33(1):12-20.
doi: 10.1177/0884217503261125.

Spinal muscular atrophy in the neonate

Affiliations
Review

Spinal muscular atrophy in the neonate

Jennifer A Markowitz et al. J Obstet Gynecol Neonatal Nurs. 2004 Jan-Feb.

Abstract

Spinal muscular atrophy (SMA) type I is an autosomal recessive disorder characterized by loss of lower motor neurons in the spinal cord. This severe hereditary neurodegenerative disorder is an important cause of morbidity in the neonate and the leading hereditary cause of infant mortality. The characteristic degeneration of anterior horn cells in the spinal cord leads to progressive muscular weakness and atrophy of the skeletal muscles. In SMA type I, the most severe form of SMA, death usually ensues by 2 years of age from respiratory failure or infection. Accurate diagnosis is now available through genetic testing, and progress is being made toward the development of therapy based on understanding of the disease mechanism. The neonatal nurse plays a pivotal role in identifying and caring for these medically fragile infants and in providing support and education for parents and families.

PubMed Disclaimer

Similar articles

Cited by

  • A schematic approach to hypotonia in infancy.
    Leyenaar J, Camfield P, Camfield C. Leyenaar J, et al. Paediatr Child Health. 2005 Sep;10(7):397-400. doi: 10.1093/pch/10.7.397. Paediatr Child Health. 2005. PMID: 19668647 Free PMC article.
  • Solution structure of the core SMN-Gemin2 complex.
    Sarachan KL, Valentine KG, Gupta K, Moorman VR, Gledhill JM Jr, Bernens M, Tommos C, Wand AJ, Van Duyne GD. Sarachan KL, et al. Biochem J. 2012 Aug 1;445(3):361-70. doi: 10.1042/BJ20120241. Biochem J. 2012. PMID: 22607171 Free PMC article.
  • Risdiplam for the Use of Spinal Muscular Atrophy.
    Kakazu J, Walker NL, Babin KC, Trettin KA, Lee C, Sutker PB, Kaye AM, Kaye AD. Kakazu J, et al. Orthop Rev (Pavia). 2021 Jul 12;13(2):25579. doi: 10.52965/001c.25579. eCollection 2021. Orthop Rev (Pavia). 2021. PMID: 34745484 Free PMC article. Review.
  • Zinc-finger proteins in health and disease.
    Cassandri M, Smirnov A, Novelli F, Pitolli C, Agostini M, Malewicz M, Melino G, Raschellà G. Cassandri M, et al. Cell Death Discov. 2017 Nov 13;3:17071. doi: 10.1038/cddiscovery.2017.71. eCollection 2017. Cell Death Discov. 2017. PMID: 29152378 Free PMC article. Review.
  • Emerging treatment options for spinal muscular atrophy.
    Burnett BG, Crawford TO, Sumner CJ. Burnett BG, et al. Curr Treat Options Neurol. 2009 Mar;11(2):90-101. doi: 10.1007/s11940-009-0012-x. Curr Treat Options Neurol. 2009. PMID: 19210911

MeSH terms

Substances